Enhanced Levels of Chemokines and Their Receptors in the Colon of Microscopic Colitis Patients Indicate Mixed Immune Cell Recruitment

Table 1

Clinical characteristics of patients and controls.

	CC^a		CC-HR^b		LC^c		LC-HR^d		Control
	mRNA	Protein	mRNA	Protein	mRNA	Protein	mRNA	Protein
Number of patients	9	13	3	4	8	5	6	6	9	10
Male/female	1/8	2/11	0/3	0/4	0/8	0/5	0/6	0/6	6/3	5/5
Age (y)	66.7^e; (35–84)	62.5; (35–84)	55; (50–64)	57.3; (50–64)	69.1; (49–86)	74; (65–86)	61; (24–80)	57.8; (24–80)	61.1; (29–88)	53.4; (28–78)
Duration of disease (y)	6.7; (0–17)	6.9; (0–17)	5; (1–9)	6; (1–9)	2.4; (0–7)	1.8; (0–6)	1.2; (0–3)	2.2; (0–7)	n/a	n/a

CC: specimens from collagenous colitis; ^bCC-HR: specimens from clinically active CC patients in histopathological remission; ^cLC: specimens from lymphocytic colitis; ^dLC-HR: specimens from clinically active LC patients in histopathological remission. ^eData are shown as mean (range).